Corpus Intelligence IC Memo — HUNTSVILLE HOSPITAL 2026-04-26 05:02 UTC
IC Memo — HUNTSVILLE HOSPITAL
Investment Committee Memorandum | AL | 904 beds | Grade C | EBITDA uplift $94.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HUNTSVILLE HOSPITAL

CCN 010039 | MADISON, AL | 904 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HUNTSVILLE HOSPITAL is a 904-bed large academic medical center in MADISON, AL with $1.28B in net patient revenue and a -6.9% operating margin. The hospital serves a payer mix of 22.6% Medicare, 21.4% Medicaid, and 56.0% commercial.

Thesis: Undervalued. Our ML models identify $94.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.9% to 0.5% (+736bps).

Net Revenue HCRIS$1.28B
Current EBITDA COMPUTED$-88.2M
Operating Margin COMPUTED-6.9%
Occupancy HCRIS82.9%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS20.7%
Distress Probability ML46.0%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
314
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -6.9% places it above the state median. Among 314 size-comparable peers (452-1808 beds), the median margin is -4.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (452-1808), prioritizing same-state peers. 314 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HUNTSVILLE HOSPITAL (Target)AL904$1.28B-6.9%
ST. LUKES HOSPITALPA633$8.94B87.9%
NYU LANGONE HOSPITALSNY1618$7.24B-7.8%
STANFORD HEALTH CARECA657$6.76B3.7%
CLEVELAND CLINIC HOSPITALOH1326$6.38B-17.7%
VANDERBILT UNIVERSITY MEDICAL TN1084$5.44B-15.9%
UCSF MEDICAL CENTERCA834$5.44B-5.4%
UT MD ANDERSON CANCER CENTERTX721$4.90B-0.8%
UNIV OF MI HOSPITALS & HLTH CTMI951$4.62B-1.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $94.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$26.8M+210bp18mo
Cost to Collect4.5%2.5%$25.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$25.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$15.6M+122bp9mo
Clean Claim Rate88.0%96.0%$818K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$26.8M
Cost to Collect
$25.6M
Denial Rate Reduction
$25.3M
A/R Days Reduction
$15.6M
Clean Claim Rate
$818K
Total EBITDA Uplift$94.1M
Current EBITDA$-88.2M
+ RCM Uplift+$94.1M
Pro Forma EBITDA$5.9M
Current Margin-6.9%
Pro Forma Margin0.5%
WC Released (1x)$49.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-135.7M$359.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-135.7M$351.2M0.00x-100.0%
Bull Case9.0x11.0x$-122.1M$617.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-122.1M$637.8M0.00x-100.0%
Bear Case11.0x10.0x$-149.2M$-67.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-149.2M$-122.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 314 hospitals with 452-1808 beds
  • Same-state prioritization (n=3)
  • Comp margins: P25=-15.2% / P50=-4.6% / P75=4.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.